"Being part of this trial, knowing it will benefit others with cancer,
may have been the greatest
part of this experience."
Pete McVoy

Trying Something New

At the age of 62, Pete McVoy was diagnosed with a rare form of adrenal cancer called adrenocortical carcinoma after his physician discovered a large mass on his kidney. Considered in stage IV and with only 12-to 18-months to live, Pete began his cancer treatment.

After surgery and six months of chemotherapy, but it became clear that this type of treatment alone would not be enough to help Pete fight this cancer. With limited options, Pete turned to Christopher Hoimes, DO, at UH Seidman Cancer Center, who suggested a new form of treatment through a clinical trial. Pete jumped at the chance to try something different.

"I liked this treatment because it helped my own body fight the disease." Pete explained. The non-invasive type of treatment is called Immunotherapy. Using immunoboosters, the trial bolstered his own immune system to fight off cancer cells.

In no time, this treatment started working. Over the next year, his scans showed that his cancer cells stopped growing and in January 2016, Dr. Hoimes concluded that Pete was in deep remission. "They can't find any signs of cancer cells in my body!" Pete explained, smiling from ear-to-ear. "I couldn't ask for anything better."

"Pete is the first person to be considered in remission with his type of cancer using Immunotherapy treatment," said Dr. Hoimes. "He is continuing to receive infusions, but his care is now all about maintenance."

"I am sitting here today because of UH Seidman Cancer Center. With the new technology, there is hope out there. There now are more ways than ever to fight this disease."